Canada Companion Animal Healthcare Market, by Product, 2018-2027

Growth Outlook

• The 2027 portion of the Canada Companion Animal Healthcare Market, by Product, 2018 market is on a steady long-term growth path. Segment value stands at roughly USD 655 Mn in 2026 and is projected to reach USD 716 Mn by 2027 — a gain of about 9% over the forecast period, translating to a CAGR in the high single digits.
• Therapeutics is the biggest of 2 groups as of 2027, at 584. 16M USD (82% of the combined total).
• What the regional split looks like (2026): Therapeutics leads, holding roughly 81% of segment value — the single largest regional share. Diagnostics is the second-largest contributor.
• By 2027, Therapeutics alone is expected to reach USD 584 Mn, with Diagnostics at USD 132 Mn.

Market Dynamics

Therapeutics is the biggest of 2 groups as of 2027, at 584.16M USD (82% of the combined total).

Diagnostics is runner-up at 131.93M USD — 77% off the lead.

Therapeutics: 278.37M USD to 584.16M USD, 110% higher by 2027.

Diagnostics: 68.42M USD in 2018 to 131.93M USD by 2027, up 93%.

Add every series together and the total reaches 716.09M USD by 2027, 106% above the 2018 combined figure of 346.79M USD.

Reading A Multi-Series Chart

There are 2 separate series stacked into this one chart. Look at relative size and relative movement, not just whichever line sits highest.

Do not confuse "biggest" with "fastest-growing" — they are frequently different series on a chart like this one, and the gap between them can close faster than the current ranking suggests.

Treat these values as a directional estimate of the Canada Companion Animal Healthcare market. They are most useful for comparing segments and regions against each other, and for spotting where demand is expected to build fastest.

This is a market research forecast, not an official statistic. Values after the 2018 base year are modeled projections to 2027, based on supply-side and demand-side analysis, and are updated when market conditions change.